Depression and cardiovascular disease in women: Behavioral and biological mechanisms involved in this association

D. A. Chirinos, Neil Schneiderman

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Cardiovascular disease (CVD) and depression are conditions that frequently co-occur, particularly among women. It has been estimated that about one in every five patients with CVD meets criteria for major depressive disorder, and an even greater number endorse subclinical levels of depressive symptoms. Most importantly, prospective studies have demonstrated that depression is a strong predictor of CVD onset, cardiac adverse events, and mortality from CVD. This association appears to be more pronounced among women. As evidence accumulates, great interest has been given to putative mechanisms that may account for this association and both behavioral and biological pathways have been proposed. The leading behavioral hypotheses suggest depression is likely to increase the risk of CVD through its influence on medication adherence and/or poor health behaviors. Biological pathways posited to link these two conditions include the inflammatory response, hypothalamic-pituitary-adrenal axis activity, genetic influences, and the adipokine, leptin. Although further research is needed to better integrate the behavioral and biological pathways linking these two conditions, intervention efforts are already on their way. Various randomized clinical control trials targeting depressive symptoms among men and women with CVD have been conducted, increasing our knowledge on how to safely address depression in the context of CVD.

Original languageEnglish (US)
Title of host publicationPsychosocial Stress and Cardiovascular Disease in Women: Concepts, Findings, Future Perspectives
PublisherSpringer International Publishing
Pages41-61
Number of pages21
ISBN (Print)9783319092416, 9783319092409
DOIs
StatePublished - Jan 1 2015

Fingerprint

Cardiovascular Diseases
Depression
Disease
Adipokines
Medication Adherence
Health Behavior
Major Depressive Disorder
Leptin
health behavior
medication
Randomized Controlled Trials
mortality
Prospective Studies
Mortality
event
Research
evidence

Keywords

  • Cardiovascular disease
  • Depression
  • Exhaustion
  • Fatigue
  • Gender
  • Inflammation
  • Interventions
  • Somatic symptom

ASJC Scopus subject areas

  • Psychology(all)
  • Medicine(all)
  • Social Sciences(all)

Cite this

Chirinos, D. A., & Schneiderman, N. (2015). Depression and cardiovascular disease in women: Behavioral and biological mechanisms involved in this association. In Psychosocial Stress and Cardiovascular Disease in Women: Concepts, Findings, Future Perspectives (pp. 41-61). Springer International Publishing. https://doi.org/10.1007/978-3-319-09241-6_5

Depression and cardiovascular disease in women : Behavioral and biological mechanisms involved in this association. / Chirinos, D. A.; Schneiderman, Neil.

Psychosocial Stress and Cardiovascular Disease in Women: Concepts, Findings, Future Perspectives. Springer International Publishing, 2015. p. 41-61.

Research output: Chapter in Book/Report/Conference proceedingChapter

Chirinos, DA & Schneiderman, N 2015, Depression and cardiovascular disease in women: Behavioral and biological mechanisms involved in this association. in Psychosocial Stress and Cardiovascular Disease in Women: Concepts, Findings, Future Perspectives. Springer International Publishing, pp. 41-61. https://doi.org/10.1007/978-3-319-09241-6_5
Chirinos DA, Schneiderman N. Depression and cardiovascular disease in women: Behavioral and biological mechanisms involved in this association. In Psychosocial Stress and Cardiovascular Disease in Women: Concepts, Findings, Future Perspectives. Springer International Publishing. 2015. p. 41-61 https://doi.org/10.1007/978-3-319-09241-6_5
Chirinos, D. A. ; Schneiderman, Neil. / Depression and cardiovascular disease in women : Behavioral and biological mechanisms involved in this association. Psychosocial Stress and Cardiovascular Disease in Women: Concepts, Findings, Future Perspectives. Springer International Publishing, 2015. pp. 41-61
@inbook{e7ce4d7c181e4b7d83df9167109b41c4,
title = "Depression and cardiovascular disease in women: Behavioral and biological mechanisms involved in this association",
abstract = "Cardiovascular disease (CVD) and depression are conditions that frequently co-occur, particularly among women. It has been estimated that about one in every five patients with CVD meets criteria for major depressive disorder, and an even greater number endorse subclinical levels of depressive symptoms. Most importantly, prospective studies have demonstrated that depression is a strong predictor of CVD onset, cardiac adverse events, and mortality from CVD. This association appears to be more pronounced among women. As evidence accumulates, great interest has been given to putative mechanisms that may account for this association and both behavioral and biological pathways have been proposed. The leading behavioral hypotheses suggest depression is likely to increase the risk of CVD through its influence on medication adherence and/or poor health behaviors. Biological pathways posited to link these two conditions include the inflammatory response, hypothalamic-pituitary-adrenal axis activity, genetic influences, and the adipokine, leptin. Although further research is needed to better integrate the behavioral and biological pathways linking these two conditions, intervention efforts are already on their way. Various randomized clinical control trials targeting depressive symptoms among men and women with CVD have been conducted, increasing our knowledge on how to safely address depression in the context of CVD.",
keywords = "Cardiovascular disease, Depression, Exhaustion, Fatigue, Gender, Inflammation, Interventions, Somatic symptom",
author = "Chirinos, {D. A.} and Neil Schneiderman",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-319-09241-6_5",
language = "English (US)",
isbn = "9783319092416",
pages = "41--61",
booktitle = "Psychosocial Stress and Cardiovascular Disease in Women: Concepts, Findings, Future Perspectives",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Depression and cardiovascular disease in women

T2 - Behavioral and biological mechanisms involved in this association

AU - Chirinos, D. A.

AU - Schneiderman, Neil

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Cardiovascular disease (CVD) and depression are conditions that frequently co-occur, particularly among women. It has been estimated that about one in every five patients with CVD meets criteria for major depressive disorder, and an even greater number endorse subclinical levels of depressive symptoms. Most importantly, prospective studies have demonstrated that depression is a strong predictor of CVD onset, cardiac adverse events, and mortality from CVD. This association appears to be more pronounced among women. As evidence accumulates, great interest has been given to putative mechanisms that may account for this association and both behavioral and biological pathways have been proposed. The leading behavioral hypotheses suggest depression is likely to increase the risk of CVD through its influence on medication adherence and/or poor health behaviors. Biological pathways posited to link these two conditions include the inflammatory response, hypothalamic-pituitary-adrenal axis activity, genetic influences, and the adipokine, leptin. Although further research is needed to better integrate the behavioral and biological pathways linking these two conditions, intervention efforts are already on their way. Various randomized clinical control trials targeting depressive symptoms among men and women with CVD have been conducted, increasing our knowledge on how to safely address depression in the context of CVD.

AB - Cardiovascular disease (CVD) and depression are conditions that frequently co-occur, particularly among women. It has been estimated that about one in every five patients with CVD meets criteria for major depressive disorder, and an even greater number endorse subclinical levels of depressive symptoms. Most importantly, prospective studies have demonstrated that depression is a strong predictor of CVD onset, cardiac adverse events, and mortality from CVD. This association appears to be more pronounced among women. As evidence accumulates, great interest has been given to putative mechanisms that may account for this association and both behavioral and biological pathways have been proposed. The leading behavioral hypotheses suggest depression is likely to increase the risk of CVD through its influence on medication adherence and/or poor health behaviors. Biological pathways posited to link these two conditions include the inflammatory response, hypothalamic-pituitary-adrenal axis activity, genetic influences, and the adipokine, leptin. Although further research is needed to better integrate the behavioral and biological pathways linking these two conditions, intervention efforts are already on their way. Various randomized clinical control trials targeting depressive symptoms among men and women with CVD have been conducted, increasing our knowledge on how to safely address depression in the context of CVD.

KW - Cardiovascular disease

KW - Depression

KW - Exhaustion

KW - Fatigue

KW - Gender

KW - Inflammation

KW - Interventions

KW - Somatic symptom

UR - http://www.scopus.com/inward/record.url?scp=84943601183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943601183&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-09241-6_5

DO - 10.1007/978-3-319-09241-6_5

M3 - Chapter

AN - SCOPUS:84943601183

SN - 9783319092416

SN - 9783319092409

SP - 41

EP - 61

BT - Psychosocial Stress and Cardiovascular Disease in Women: Concepts, Findings, Future Perspectives

PB - Springer International Publishing

ER -